References
- Adams E, Boulton M, Horne A, Rose P, Durrant L, Collingwood M, Ozkrochi R, Davidson S & Watson E. (2014). The Effects of Pelvic Radiotherapy on Cancer Survivors: Symptom Profile, Psychological Morbidity and Quality of Life. Clinical Oncology, 26: 10–17.
- Clegg M, Pye J & Wylie KR. (2016). Undergraduate Training in Human Sexuality—Evaluation of the Impact on Medical Doctors’ Practice Ten Years After Graduation, Journal of Sexual Medicine, e1–e11.
- Forbat L, White I, Marshall-Lucette S, Kelly D. (2011). Discussing the sexual consequences of treatment in radiotherapy and urology consultations with couples affected by prostate cancer. British Journal of Urology International , 109: 98–103.
- Galletly C, Lechuga J, Layde JB, et al. (2010) Sexual health curricula in US medical schools: Current educational objectives. Acad Psychiatry, 34:333–338.
- Kirby M G, White ID, Butcher J, Challacombe B, Coe J, Grover L, Hegarty P, Jackson G, Lowndes A, Payne H, Rees J, Sangar V, Thompson A. (2014). Development of UK recommendations on treatment for post-surgical erectile dysfunction. International Journal of Clinical Practice, doi: 10.1111/ijcp.1233, 1–17.
- Macmillan Cancer Support. (2013). Throwing light on the consequences of cancer and its treatment, London: Macmillan.
- White ID, Allan H & Faithfull S. (2011). Assessment of treatment-induced female sexual morbidity in oncology: is this a part of routine medical follow-up after radical pelvic radiotherapy? British Journal of Cancer, 105: 903–910.
- White ID, Faithfull S & Allan H. (2013) The re-construction of women's sexual lives after pelvic radiotherapy: A critique of social constructionist and biomedical perspectives on the study of female sexuality after cancer treatment. Social Science & Medicine, 76: 188–196.
- White ID, Wilson J, Aslet P, Baxter AB, Birtle A, Challacombe B, Coe J, Grover L, Payne H, Russell S, Sangar V, Van As N, Kirby M. (2015). Development of UK guidance on the management of erectile dysfunction resulting from radical radiotherapy and androgen deprivation therapy for prostate cancer. International Journal of Clinical Practice, 69 (1) 106–123. doi:10.1111/ijcp.12512